With the observed effect of boosted apoptosis in the combination treatment with TGFβ1 + MEKi, we create a context, in which the outcome of TGFβ signaling is drastically rewired from increasing invasiveness to promoting apoptosis, even in MEKi-resistant melanoma cells. Here, TGFB1 is linked to melanoma.